Totem BioSciences is an emerging biotechnology company focused on the development of immunotherapies and vaccines for the protection of our companion animals and livestock. We focus on facilitating the animal’s own innate immunity to protect against pathogenic infections and cancers.
Totem’s team has a successful track record in the discovery and development of protective immunotherapies and vaccine adjuvants in the biotechnology and pharmaceutical industries. We have significant expertise in the discovery and development of Toll-Like Receptor (TLR) agonists as vaccine adjuvants and stand alone immune-modulators, taking new chemical entities through clinical trials to licensure. Our focus now is to utilize this experience for the benefit of animal well-being products.